MCP marches, PFE trades widely, MCOX falls

Molycorp. Inc (NYSE: MCP) was a winner Monday, muscling up 18.06 percent in price to $32.82. Volume of 7,226,528 shares was near triple MCP’s normal full-day average volume. Colorado-based Molycorp, Inc. is the only rare earth oxide (REO) producer in the Western hemisphere and currently produces approximately 3,000 tons of commercial rare earth materials per year.

Pfizer Inc. (NYSE: PFE) traded in 45,357,434shares, making it a leader in volume, edging its daily average of 42,923,900. Shares in PFE inched up 0.42 percent to close Monday at $16.83. PFE announced today that a significantly higher proportion of patients with newly diagnosed chronic myeloid leukemia who were treated with bosutinib (39% ) experienced a major molecular response (MMR), a secondary endpoint, compared with patients treated with imatinib (26% ) in the intent-to-treat population

Mecox Lane Ltd. (NasdaqGM: MCOX) faded in price 11.54 percent Monday afternoon to wind up at $6.90, on volume of 1,491,840 shares, slightly above its daily volume average. MCOX operates China’s leading online platform for apparel and accessories as measured by revenues in 2009.

Tags: biopharmaceuticals, china stocks, consumer discretionary, Energy Stocks, mcox, MCP, nasdaq, NYSE, PFE, pharmaceutical stocks

This entry was posted on Monday, December 6th, 2010 at 4:29 pm by Glenn and is filed under Consumer Discretionary Stocks, Energy Stocks, pharmaceutical stocks. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.